Senior insider sale
Chief People Officer at AMICUS THERAPEUTICS, INC. — senior position signals high conviction
$1.06M
102.57K shares
What this filing means
CLARK DAVID MICHAEL plans to sell 102.57K shares of AMICUS THERAPEUTICS, INC. valued at approximately $1.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/19/2025ACC: 0001950047-25-010560
Officer· Chief People Officer
Since Oct 2018
102.57K
Shares to sell
$1.06M
Approx. market value
25.64K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/2/2025
25.64KTotal acquired25.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2025 | Restricted Stock Units N/A | 25.64K | — |
| Total | 25.64K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
25.64K
Market value
$282.1K
12/15/2025
—Completed
Units to sell
25.64K
Market value
$258.9K
11/24/2025
—Completed
Units to sell
25.64K
Market value
$243.9K
11/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.64K
Market value
$279.2K
12/19/2025
Total
Units
102.57K
Value
$1.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2025 | 25.64K | $282.1K | — | Completed |
11/24/2025 | 25.64K | $258.9K | — | Completed |
11/4/2025 | 25.64K | $243.9K | — | Completed |
| Planned — Approximate Date | ||||
12/19/2025 | 25.64K | $279.2K | NASDAQ | Planned |
| Total | 102.57K | $1.06M | ||